Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response

被引：39
作者：
Wu, Yi-Ying [1 ,2 ]
Sun, Te-Kai [3 ]
Chen, Ming-Shan [4 ]
Munir, Muhammad [5 ]
Liu, Hung-Jen [1 ,2 ,6 ,7 ,8 ]
机构：
[1] Natl Chung Hsing Univ, Inst Mol Biol, Taichung, Taiwan
[2] Natl Chung Hsing Univ, iEGG & Anim Biotechnol Ctr, Taichung, Taiwan
[3] Tsairder Boitechnol Co Ltd, Taichung, Taiwan
[4] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Anesthesiol, Chiayi, Taiwan
[5] Univ Lancaster, Dept Biomed & Life Sci, Lancaster, Lancs, England
[6] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan
[7] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung, Taiwan
[8] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan
来源：
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2023年 / 13卷
关键词：
oncolytic viruses; virotherapy; immunotherapy; apoptosis; immune system; autophagy; immunogenic cell death; NEWCASTLE-DISEASE VIRUS; AVIAN REOVIRUS; T-CELL; LUNG-CANCER; IN-VITRO; PHASE-I; GM-CSF; ADENOVIRUS; INDUCTION; THERAPY;
D O I：
10.3389/fcimb.2023.1142172
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Recent reports have revealed that oncolytic viruses (OVs) play a significant role in cancer therapy. The infection of OVs such as oncolytic vaccinia virus (OVV), vesicular stomatitis virus (VSV), parvovirus, mammalian reovirus (MRV), human adenovirus, Newcastle disease virus (NDV), herpes simplex virus (HSV), avian reovirus (ARV), Orf virus (ORFV), inactivated Sendai virus (ISV), enterovirus, and coxsackievirus offer unique opportunities in immunotherapy through diverse and dynamic pathways. This mini-review focuses on the mechanisms of OVs-mediated virotherapy and their effects on immunogenic cell death (ICD), apoptosis, autophagy and regulation of the immune system.
引用
收藏
页数：13
相关论文
共 174 条
[1]   Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus AdΔΔ through Bcl-2-dependent attenuation of autophagy [J].
Aguirre-Hernandez, Carmen ;
Maya-Pineda, Hector ;
San Millan, Julia ;
Man, Y. K. Stella ;
Lu, Yong-Jie ;
Hallden, Gunnel .
ONCOGENESIS, 2018, 7
[2]   Targeting immunogenic cell death in cancer [J].
Ahmed, Asma ;
Tait, Stephen W. G. .
MOLECULAR ONCOLOGY, 2020, 14 (12) :2994-3006
[3]   Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer [J].
Ang, Lin ;
Li, Jiang ;
Dong, Hui ;
Wang, Chunhong ;
Huang, Jin ;
Li, Mingcong ;
Zhao, Min ;
Su, Changqing ;
Wu, Qiang .
BIOENGINEERING-BASEL, 2022, 9 (08)
[4]   Complementary Induction of Immunogenic Cell Death by Oncolytic Parvovirus H-1PV and Gemcitabine in Pancreatic Cancer [J].
Angelova, Assia L. ;
Grekova, Svitlana P. ;
Heller, Anette ;
Kuhlmann, Olga ;
Soyka, Esther ;
Giese, Thomas ;
Aprahamian, Marc ;
Bour, Gaetan ;
Rueffer, Sven ;
Cziepluch, Celina ;
Daeffler, Laurent ;
Rommelaere, Jean ;
Werner, Jens ;
Raykov, Zahari ;
Giese, Nathalia A. .
JOURNAL OF VIROLOGY, 2014, 88 (10) :5263-5276
[5]   Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer [J].
Araki, Hiroyuki ;
Tazawa, Hiroshi ;
Kanaya, Nobuhiko ;
Kajiwara, Yoshinori ;
Yamada, Motohiko ;
Hashimoto, Masashi ;
Kikuchi, Satoru ;
Kuroda, Shinji ;
Yoshida, Ryuichi ;
Umeda, Yuzo ;
Urata, Yasuo ;
Kagawa, Shunsuke ;
Fujiwara, Toshiyoshi .
MOLECULAR THERAPY-ONCOLYTICS, 2022, 27 :3-13
[6]  
Askari Fatemeh Sana, 2021, Asian Pac J Cancer Prev, V22, P249, DOI 10.31557/APJCP.2021.22.1.249
[7]   Polytherapeutic strategies with oncolytic virus-bortezomib and adjuvant NK cells in cancer treatment [J].
Aspirin, Angelica P. ;
de los Reyes, Aurelio A., V ;
Kim, Yangjin .
JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2021, 18 (174)
[8]  
Au GG, 2005, INT J ONCOL, V26, P1471
[9]   Avian reovirus:: Structure and biology [J].
Benavente, Javier ;
Martinez-Costas, Jose .
VIRUS RESEARCH, 2007, 123 (02) :105-119
[10]   Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma [J].
Bommareddy, Praveen K. ;
Zloza, Andrew ;
Rabkin, Samuel D. ;
Kaufman, Howard L. .
ONCOIMMUNOLOGY, 2019, 8 (07)
12345678910